Capillary Applied sciences India Ltd., a Bengaluru-based SaaS chief providing AI-driven loyalty and buyer engagement options, is developing with its IPO opening on 14 November 2025. The corporate has proven a powerful restoration in recent times with bettering profitability, diversified international clientele, and a scalable cloud-based platform. Nevertheless, the IPO valuation seems aggressive based mostly on present financials. On this detailed Capillary Applied sciences IPO Evaluate, we cowl key areas together with firm evaluation, aggressive strengths, financials, IPO difficulty particulars, valuation, GMP, causes to speculate, danger elements, subscription insights, and whether or not it’s best to subscribe or keep away from this IPO.
About Capillary Applied sciences India Ltd.
Based in 2008, Capillary Applied sciences is a distinguished SaaS firm offering buyer loyalty applications, omnichannel CRM instruments, and superior engagement platforms for enterprise manufacturers.
Key choices embody:
- Loyalty+ – Enterprise-grade loyalty administration system.
- Interact+ – AI-driven customized communication suite.
- Insights+ – Knowledge analytics and predictive intelligence.
- Rewards+ – Reward catalog and incentive administration.
- Omnichannel CRM and real-time engagement instruments.
Consumer Base & World Attain
Capillary serves 250+ international manufacturers throughout 30+ nations, together with:
- Tata Group
- Shell
- Domino’s
- PUMA
- Jockey
Income is generated primarily by a subscription-based SaaS mannequin.
Aggressive Strengths
1. Market Chief in Loyalty Administration
Capillary is certainly one of India’s strongest gamers within the enterprise loyalty area, powering a number of large-scale applications throughout industries comparable to retail, FMCG, vitality, and hospitality.
2. Robust, Diversified Lengthy-Time period Buyer Relationships
The corporate enjoys excessive renewal charges and strong Web Income Retention (NRR), displaying sturdy stickiness.
3. AI-Powered, Cloud-Native Platform
Capillary’s cloud-first, microservices-based structure gives sturdy scalability, safety, and integration capabilities.
4. Rising World Enlargement
Vital share of income now comes from Center East and SE Asia markets, lowering dependency on India.
5. Return to Profitability
After losses till FY24, the corporate reported earnings in FY25 and H1 FY26, indicating enterprise turnaround.
Capillary Applied sciences IPO Challenge Particulars
- IPO Open Date: 14 Nov 2025
- IPO Shut Date: 18 Nov 2025
- Challenge Dimension: ₹877.50 crore
- Contemporary Challenge: ₹345 crore
- Supply for Sale (OFS): ₹532.50 crore
- Value Band: ₹549 – ₹577 per share
- Lot Dimension: 25 shares
- Minimal Funding (Retail): ₹14,425
- Itemizing: BSE & NSE
- Registrar: MUFG Intime India Pvt. Ltd.
- BRLM: JM Monetary Ltd.
Financials of Capillary Applied sciences
(₹ in Crores)
| Interval | Complete Earnings | PAT | EBITDA | Web Value | Borrowings |
|---|---|---|---|---|---|
| 30 Sep 2025 | 362.56 | 1.03 | 39.82 | 509.38 | 88.94 |
| FY25 | 611.87 | 14.15 | 78.57 | 481.42 | 100.09 |
| FY24 | 535.44 | -68.35 | -1.49 | 452.13 | 77.17 |
| FY23 | 266.25 | -88.56 | -58.34 | 99.75 | 147.47 |
Key Monetary Highlights
- Income grew at over 14% YoY.
- PAT moved from lack of ₹68 Cr in FY24 to revenue of ₹14+ Cr in FY25.
- Debt/fairness stands at 0.18, displaying a cushty leverage place.
- EBITDA margins improved to 13% in FY25.
The corporate is clearly in a turnaround section.
Valuation & P/E Comparability
- Pre-issue P/E: 298x
- Put up-issue P/E: 2,214x
These values seem considerably overvalued vs business benchmarks.
Peer Comparability (Illustrative SaaS/Tech Gamers)
| Firm | P/E | Remarks |
|---|---|---|
| Happiest Minds | ~70x | Trade common approx |
| Tata Elxsi | ~55x | Giant-cap digital engineering |
| Route Cell (Highest P/E in friends) | ~95x | Excessive-growth CPaaS |
| Brightcom (Lowest P/E in friends) | ~10x | Distressed valuations |
| Trade Common | 50–70x | Mature SaaS & Digital Tech |
| Capillary Applied sciences IPO P/E | 298x – 2,214x | Extraordinarily excessive |
Conclusion on Valuation: Capillary IPO is priced at very steep valuations, far above business norms.
Objects of the Challenge
The web proceeds shall be used for:
- Funding cloud infrastructure prices – ₹120 Cr
- Funding in R&D and platform growth – ₹151.54 Cr
- Buy of laptop programs – ₹10.32 Cr
- Funding inorganic progress by acquisitions
Gray Market Premium (GMP)
As of newest updates, the Capillary Applied sciences IPO GMP is just not out there.
GMP traits assist gauge itemizing expectations, however ultimate itemizing is influenced by market sentiment and subscription numbers.
Causes to Spend money on Capillary Applied sciences IPO
1. Robust Place in Loyalty & Engagement SaaS
Capillary is a frontrunner in branded loyalty applications and CRM, a fast-growing section pushed by digital adoption.
2. Excessive-High quality Consumer Base
World manufacturers with long-term contracts guarantee predictable recurring revenues.
3. Enhancing Profitability and Margins
The corporate has efficiently moved from losses to earnings, signaling operational turnaround.
4. Scalable Platform with World Enlargement
Cloud-native structure permits straightforward enlargement into a number of geographies.
5. Elevated Spending on Buyer Engagement Globally
Loyalty and CRM options proceed to see sturdy demand, supporting long-term progress.
Danger Elements to Take into account
1. Extraordinarily Excessive IPO Valuation
The most important danger is the steep valuation—considerably larger than business friends.
2. Dependence on Giant Purchasers
Excessive focus on massive enterprise shoppers poses renewal and churn dangers.
3. Intense Competitors in SaaS
World CRM gamers (Salesforce, Adobe, Zoho) pose expertise and pricing stress.
4. Overseas Market Dependence
A big portion of future progress is determined by Center East and SE Asia—areas vulnerable to political and financial fluctuation.
5. Integration Dangers from Acquisitions
The corporate plans inorganic enlargement; acquisitions carry execution and synergy dangers.
6. Previous Historical past of Losses
Capillary reported losses for a number of years earlier than FY25. Sustaining profitability is crucial.
Apply for Capillary Applied sciences IPO
Retail traders can apply through:
- UPI-based software by brokers like Zerodha, Upstox, Groww, Angel One, ICICI Direct, and so on.
- Web Banking ASBA (Utility Supported by Blocked Quantity).
Steps:
- Log in to your buying and selling app.
- Go to IPO part.
- Choose Capillary Applied sciences IPO.
- Enter lot dimension & value (or choose cut-off for retail).
- Approve UPI mandate.
Conclusion – Ought to You Spend money on Capillary Applied sciences IPO?
Capillary Applied sciences is a powerful SaaS-based loyalty and CRM firm with a steady international shopper base, quickly rising revenues, and a return to profitability. The enterprise fundamentals and long-term prospects seem sound.
Nevertheless, the valuation is extraordinarily aggressive, with P/E multiples far above business benchmarks..
My View: Keep away from for now.
FAQs – Capillary Applied sciences IPO
1. What’s the Capillary Applied sciences IPO GMP at present?
GMP shall be up to date each day as market traits evolve.
2. Is Capillary Applied sciences a worthwhile firm?
Sure, the corporate turned worthwhile in FY25 after a number of years of losses.
3. What’s the minimal funding required?
Retail traders want a minimal of ₹14,425 for one lot.
4. How is the valuation of the IPO?
The IPO valuation is considerably larger than business averages, making it costly.
5. Who’re the promoters?
Capillary Applied sciences Worldwide Pte Ltd and Aneesh Reddy Boddu.
6. When will the shares listing?
Tentative itemizing date is 21 November 2025.
7. Is that this IPO good for long-term funding?
Good for high-risk long-term traders; valuation-sensitive traders might keep away from.
Disclaimer: This text is for informational functions solely. IPO investments are topic to market dangers. Traders ought to seek the advice of their monetary advisor earlier than investing.
